New inflammatory bowel disease drug passes first safety check in healthy volunteers
NCT ID NCT06483373
First seen May 13, 2026 · Last updated May 25, 2026 · Updated 4 times
Summary
This early-stage study tests the safety of a new drug called SPH7854 in 111 healthy adults. Researchers will monitor for side effects and measure how the drug moves through the body. This study does not aim to treat any disease, but the results will help guide future research for inflammatory bowel disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Second University Hospital, Sichuan University
RECRUITINGChengdu, China
Contact
Conditions
Explore the condition pages connected to this study.